Our extensive database of Harvard technologies is available for new product development opportunities that will strengthen your strategic portfolio.

SEARCH

Category:

AVAILABLE TECHNOLOGIES - Microbiology/Infectious Diseases

Results: 32
Case # Lead Inventor Title
4657Benjamin, Thomas L.Assessing polyomavirus-related disease risk using genetic testing
4406Hochschild, AnnBacteria based PrP and Amyloid technology generates novel aggregation assays
4068Lory, StephenDEVELOPMENT OF BROAD SPECTRUM ANTIMICROBIAL AGENTS; TARGETING THE CELL ENVELOPE BIOGENESIS PATHWAY OF GRAM-NEGATIVE; BACTERIAL PATHOGENS
3755Kasper, DennisSmall molecule inhibitors of Ebola virus entry
3272Beckwith, Jonathan R.Microbial VKOR as an anti-infective target
3248Girguis, Peter RiadRobust Biological Conversion of Methane to Electricity
3242Walker Kahne, SuzanneTargocil: Novel antibiotics against Methicillin-resistant Staphylococcus aureus (MRSA)
3219Myers, Andrew G.Synthetic route for anti-angiogenic natural products cortistatins and analogs
3133Harrison, Stephen C.A fusion intermediate state of HIV-1 gp41, targeted by broadly neutralizing antibodies, for purposes of vaccination
2985Kahne, Daniel E.Development of broad spectrum antibiotics for new targets
2937Qin, XuebinApplication of Domain 4 of ILY for treatment and prevention of foreign ; pathogen infection
2911Silver, Pamela A.Protein-based therapies using quantitatively designed proteins
2858Desrosiers, Ronald C.Vaccination against HIV using Herpesvirus
2807Maniatis, ThomasHomozygous IKKepsilon knockout mouse as an animal model for influenza virus infection
2763Girguis, Peter RiadLow cost and versatile microbial fuel cell
2704Walker Kahne, SuzanneDevelopment of broad spectrum antibiotics for new targets
2605Knipe, David M.A novel strategy for the prevention and treatment of sexually transmitted viruses
2568Whelan, Sean P.J.Attenuated RNA viruses for vaccine and drug delivery
2508Kasper, DennisPrevention of tularemia using an enhanced live attenuated vaccine strain
2406Roth, Frederick P.Simultaneous study of multiple genetic interactions using multi-mutant yeast
2347Coen, Donald M.Novel Anti-CMV Small Molecules
2301Goldberg, Alfred L.Novel candidates for Tuberculosis therapy
1903Coen, Donald M.Sensitive assay to identify inhibitors of HSV DNA polymerase
1740Rubin, Eric JosephHyperactive mutant of the Himar1 mariner transposase
1558Harrison, Stephen C.Vaccine compositions and methods for Human Papilloma Virus
1546Knipe, David M.A genetically modified herpes simplex virus that has utility as a drug screening tool
1475Mekalanos, John J.Systematic, condition-independent identification of essential genes of microorganisms
1173Coen, Donald M.High lead expression of soluble CMV UL97 and development of an assay to screen inhibitors
1127Swanson, JoelLiposome-based, intracellular delivery of drugs into phagocytes, B- and T-cells, and their tumor cells
1121Munger, KarlMethod and kit for evaluating transformed cells
0806Essex, Myron EA method for producing partially deglycosylated HIV-1 envelope glycoproteins through site-directed mutagenesis
0641Neutra, Marian R.Hydroxapatite-antigen conjugates and methods for generating a poly-Ig immune response